Broker Regulation

Benefits professionals should anticipate further guidance as they attempt to develop a workable process for determining out-of-network payment rates

Planning for compliance obligations when the PHE ends will require a review of legislation passed between 2020 and 2023.

A new report finds that brokers and agents say that carriers are incentivizing the sale of certain types of Medicare plans over others.

"The House Oversight and Accountability Committee is shining a light on this issue in the health care system and will continue to examine solutions to make prescription drugs more affordable for all Americans," says Rep. James Comer.

Benefits advisors and brokers need to understand price transparency from the participant and provider perspectives, the compliance mandates new federal regulations aim to achieve, and most importantly, what strategies benefits professionals can take to optimize their role and value.

Renewal of the state's contract to procure specialty pharmacy prescriptions, which was set to take effect May 1, was halted after the pharmacy chain announced its refusal to sell mifepristone in 20 states.